Subject 0 7 0 7 O
who 8 11 8 11 O
has 12 15 12 15 O
a 16 17 16 17 O
known 18 23 18 23 O
hypersensitivity 24 40 24 40 O
to 41 43 41 43 O
risankizumab 44 56 44 56 B-allergy_name
or 57 59 57 59 O
the 60 63 60 63 O
excipients 64 74 64 74 O
of 75 77 75 77 O
any 78 81 78 81 O
of 82 84 82 84 O
the 85 88 85 88 O
study 89 94 89 94 O
drugs 95 100 95 100 O
or 101 103 101 103 O
the 104 107 104 107 O
ingredients 108 119 108 119 O
of 120 122 120 122 O
CHO 123 126 123 126 B-allergy_name
, 126 127 126 127 O
or 128 130 128 130 O
had 131 134 131 134 O
an 135 137 135 137 O
AE 138 140 138 140 O
during 141 147 141 147 O
Studies 148 155 148 155 O
M16 156 159 156 159 O
- 159 160 159 160 O
006 160 163 160 163 O
, 163 164 163 164 O
M15 165 168 165 168 O
- 168 169 168 169 O
991 169 172 169 172 O
or 173 175 173 175 O
M15 176 179 176 179 O
- 179 180 179 180 O
989 180 183 180 183 O
that 184 188 184 188 O
in 189 191 189 191 O
the 192 195 192 195 O
Investigator 196 208 196 208 O
's 208 210 208 210 O
judgment 211 219 211 219 O
makes 220 225 220 225 O
the 226 229 226 229 O
subject 230 237 230 237 O
unsuitable 238 248 238 248 O
for 249 252 249 252 O
this 253 257 253 257 O
study 258 263 258 263 O

